Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Oct 24 | TVTX Travere Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 15.1547 | 18,821 | 285.23 k | 51,000 |
4 Oct 24 | TVTX Travere Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 14.3479 | 21,179 | 303.87 k | 69,821 |
4 Oct 24 | TVTX Travere Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 10.48 | 40,000 | 419.20 k | 91,000 |
4 Oct 24 | TVTX Travere Therapeutics | Stock option Common Stock | Option exercise | Acquire M | No | No | 10.48 | 40,000 | 419.20 k | 0 |
13 Aug 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 150.4278 | 11,570 | 1.74 mm | 119,047 |
13 Aug 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 42.76 | 11,570 | 494.73 k | 130,617 |
13 Aug 24 | NBIX Neurocrine Biosciences | NQSO Common Stock | Option exercise | Dispose M | No | No | 42.76 | 11,570 | 494.73 k | 0 |
16 Jul 24 | NBIX Neurocrine Biosciences | Common Stock | Sell | Dispose S | No | Yes | 150.0325 | 930 | 139.53 k | 119,047 |
16 Jul 24 | NBIX Neurocrine Biosciences | Common Stock | Option exercise | Acquire M | No | No | 42.76 | 930 | 39.77 k | 119,977 |
16 Jul 24 | NBIX Neurocrine Biosciences | NQSO Common Stock | Option exercise | Dispose M | No | No | 42.76 | 930 | 39.77 k | 11,570 |